STN–ANT plasticity is crucial for the motor control in Parkinson’s disease model

Hui Zhang, Chunkui Zhang, Zhongwei Qu, Bing Li, Yujuan Su, Xia Li, Yan Gao, Yizheng WangSignal 2021 · DOI · OpenAlex

Introduction

Parkinson’s Disease (PD) is traditionally characterized by dopamine depletion leading to overactivity in the subthalamic nucleus (STN) and globus pallidus internus (GPi). While current therapies like Deep Brain Stimulation (DBS) target these canonical circuits, they often fail to alleviate complex motor symptoms such as gait instability. This research identifies a previously overlooked excitatory pathway from the STN to the anterior thalamic nucleus (ANT) that plays a critical role in PD-related motor dysfunction.

Methods

The study utilized rodent models of PD (6-OHDA and MPTP-induced). Researchers employed viral tracing to map the STN–ANT connection, optogenetics (ChR2 and eNpHR) to manipulate circuit activity, and whole-cell electrophysiology to record synaptic changes. Behavioral assays, including balance beam and rotation tests, were used to assess motor function. Molecular mechanisms were investigated via Western blotting and the development of a targeted cell-permeable peptide, TAT-S845.

Maladaptive Synaptic Plasticity in the STN–ANT Circuit

The authors discovered that the STN–ANT synapse undergoes pathological Long-Term Potentiation (LTP) in PD models. This maladaptive plasticity is characterized by an increased AMPAR/NMDAR ratio and the recruitment of GluR2-lacking AMPA receptors, leading to neuronal hyperexcitability and increased firing rates in the ANT.

Schematic of the STN–ANT synapse showing PKA-mediated GluR1-S845 phosphorylation and increased receptor density in the PD model.

Crucially, this process is driven by the phosphorylation of the GluR1 subunit at the Serine 845 (S845) site, mediated by Protein Kinase A (PKA). This molecular signature was specific to the STN–ANT pathway, distinguishing it from the traditional STN–GPi circuit.

Motor Rescue through Circuit Inhibition

Targeting this circuit proved highly effective in restoring motor function. Lesioning the ANT or optogenetically inhibiting the STN–ANT projections significantly improved performance on the balance beam and reduced pathological rotation behavior.

Optogenetic inhibition of the STN–ANT circuit (eNpHR) reduces pathological firing and improves motor performance in PD models.

Furthermore, pharmacological blockade of S845 phosphorylation—using either the PKA inhibitor H-89 or the novel TAT-S845 peptide—reversed the synaptic strengthening and alleviated motor deficits. These findings suggest that the STN–ANT circuit is a viable therapeutic target for treating PD symptoms that are resistant to conventional therapies.

Conclusion and Future Directions

This study highlights the importance of non-canonical basal ganglia circuits in Parkinson’s Disease. The discovery of STN–ANT maladaptive plasticity provides a new molecular target for intervention. Future work is needed to understand why this plasticity is circuit-specific and to validate these findings in human patients, potentially opening doors for more precise neuromodulation or pharmacological treatments.

Summary updated

BibTeX
@inproceedings{zhang2021stnant,
  author = {Hui Zhang and Chunkui Zhang and Zhongwei Qu and Bing Li and Yujuan Su and Xia Li and Yan Gao and Yizheng Wang},
  title = {{STN–ANT plasticity is crucial for the motor control in Parkinson’s disease model}},
  booktitle = {Signal},
  year = {2021},
  doi = {10.1038/s41392-021-00545-z},
}
Figure